Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection
Author(s) -
Jonas Brinck,
Aurélien Thomas,
Estelle Lauer,
François R. Jornayvaz,
MarieClaude BrulhartMeynet,
JeanChristophe Prost,
Zoltan Pataky,
Patrik Löfgren,
Johan Hoffstedt,
Mats Eriksson,
Camilla Pramfalk,
Sandrine Morel,
Brenda R. Kwak,
Miranda Van Eck,
Richard W. James,
Miguel A. Frias
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.307049
Subject(s) - glycation , medicine , endocrinology , glycated hemoglobin , diabetes mellitus , oxidative stress , high density lipoprotein , lipoprotein , type 2 diabetes , cholesterol
The dyslipidemia of type 2 diabetes mellitus has multiple etiologies and impairs lipoprotein functionality, thereby increasing risk for cardiovascular disease. High-density lipoproteins (HDLs) have several beneficial effects, notably protecting the heart from myocardial ischemia. We hypothesized that glycation of HDL could compromise this cardioprotective effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom